CoMMiT: Co-informed inference of microbiome-metabolome interactions via transfer learning
Authors:
Leiyue Li,
Chenglong Ye,
Tim Randolph,
Meredith Hullar,
Johanna Lampe,
Marian Neuhouser,
Daniel Raftery,
Yue Wang
Abstract:
Recent multi-omic microbiome studies enable integrative analysis of microbes and metabolites, uncovering their associations with various host conditions. Such analyses require multivariate models capable of accounting for the complex correlation structures between microbes and metabolites. However, existing multivariate models often suffer from low statistical power for detecting microbiome-metabo…
▽ More
Recent multi-omic microbiome studies enable integrative analysis of microbes and metabolites, uncovering their associations with various host conditions. Such analyses require multivariate models capable of accounting for the complex correlation structures between microbes and metabolites. However, existing multivariate models often suffer from low statistical power for detecting microbiome-metabolome interactions due to small sample sizes and weak biological signals. To address these challenges, we introduce CoMMiT, Co-informed inference of Microbiome-Metabolome Interactions via novel Transfer learning models. Unlike conventional transfer-learning methods that borrow information from external datasets, CoMMiT leverages similarities across metabolites within a single cohort, reducing the risk of negative transfer often caused by differences in sequencing platforms and bioinformatic pipelines across studies. CoMMiT operates under the flexible assumption that auxiliary metabolites are collectively informative for the target metabolite, without requiring individual auxiliary metabolites to be informative. CoMMiT uses a novel data-driven approach to selecting the optimal set of auxiliary metabolites. Using this optimal set, CoMMiT employs a de-biasing framework to enable efficient calculation of p-values, facilitating the identification of statistically significant microbiome-metabolome interactions. Applying CoMMiT to a feeding study reveals biologically meaningful microbiome-metabolome interactions under a low glycemic load diet, demonstrating the diet-host link through gut metabolism.
△ Less
Submitted 30 June, 2025;
originally announced June 2025.
Variable selection with FDR control for noisy data -- an application to screening metabolites that are associated with breast and colorectal cancer
Authors:
Runqiu Wang,
Ran Dai,
Ying Huang,
Marian L. Neuhouser,
Johanna W. Lampe,
Daniel Raftery,
Fred K. Tabung,
Cheng Zheng
Abstract:
The rapidly expanding field of metabolomics presents an invaluable resource for understanding the associations between metabolites and various diseases. However, the high dimensionality, presence of missing values, and measurement errors associated with metabolomics data can present challenges in developing reliable and reproducible methodologies for disease association studies. Therefore, there i…
▽ More
The rapidly expanding field of metabolomics presents an invaluable resource for understanding the associations between metabolites and various diseases. However, the high dimensionality, presence of missing values, and measurement errors associated with metabolomics data can present challenges in developing reliable and reproducible methodologies for disease association studies. Therefore, there is a compelling need to develop robust statistical methods that can navigate these complexities to achieve reliable and reproducible disease association studies. In this paper, we focus on developing such a methodology with an emphasis on controlling the False Discovery Rate during the screening of mutual metabolomic signals for multiple disease outcomes. We illustrate the versatility and performance of this procedure in a variety of scenarios, dealing with missing data and measurement errors. As a specific application of this novel methodology, we target two of the most prevalent cancers among US women: breast cancer and colorectal cancer. By applying our method to the Wome's Health Initiative data, we successfully identify metabolites that are associated with either or both of these cancers, demonstrating the practical utility and potential of our method in identifying consistent risk factors and understanding shared mechanisms between diseases.
△ Less
Submitted 10 October, 2023;
originally announced October 2023.
